razoxane has been researched along with Cancer of Cervix in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belloni, C; Bortolozzi, G; Carinelli, S; D'Incalci, M; Maggioni, A; Mangioni, C; Morasca, L | 1 |
| Blessing, JA; Conroy, JF; Hatch, K; Lewis, GC; Mangan, C; Wilbanks, G | 1 |
| Blessing, JA; Bonomi, P; Yordan, E | 1 |
| Berman, M; Blessing, JA; Homesley, HD | 1 |
2 trial(s) available for razoxane and Cancer of Cervix
| Article | Year |
|---|---|
ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma. A double-blind study.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Neoplasm Staging; Piperazines; Placebos; Razoxane; Uterine Cervical Neoplasms | 1983 |
Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot Study.
Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Cervical Neoplasms | 1988 |
2 other study(ies) available for razoxane and Cancer of Cervix
| Article | Year |
|---|---|
ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.
Topics: Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukopenia; Piperazines; Razoxane; Thrombocytopenia; Uterine Cervical Neoplasms | 1984 |
ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Cervical Neoplasms | 1986 |